comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 16:11:40 - browse：2

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： HPV vaccine, cervical cancer study delivers historic results

WSS

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Mass General, Mayo Clinic look to monetize custom

Head of FDA's diagnostics center, who led through Covid, retires

CVS is on a mission to consolidate health care. Will it work?

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Update the Apgar Score to remove skin color

focus

comprehensive

leisure time

Activists slam private health insurers over coverage restrictions

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Continuity nursing helped my family in our darkest PICU moments

FDA sets aggressive timeline for overhauling inspection procedures

Bright Health sells Medicare Advantage business to Molina

What we know about the American soldier detained in North Korea

After affirmative action ruling, medical educators look to 'holistic review'

Flagship, Pfizer team up in deal worth up to $7 billion

Dobbs anniversary: the lost opportunity of abortion as health care

What we know about the American soldier detained in North Korea

explore

House passes resolution saying Israel isn't a 'racist or apartheid state'

There's an unseen cost to disruptive road

House passes resolution saying Israel isn't a 'racist or apartheid state'

HPV vaccine, cervical cancer study delivers historic results

A Theranos scientist

The inclusion problem at the heart of rehabilitation research

explore

knowledge

hotspot

hotspot